FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileBiome Australia Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
BIO.AX
Biome Australia Limited Stock AnalysisComprehensive stock analysis for Biome Australia Limited (BIO.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisBIO.AX
BIO.AX
Biome Australia Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
BIO.AX
  1. Home
  2. Stocks
  3. Biome Australia Limited

Biome Australia Limited

🇦🇺BIO.AX•ASX

Biome Australia Limited

🇦🇺BIO.AX•ASX
P/E ratio
21.74

Your view on BIO.AX

P/E
21.74
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Biome Australia Limited

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Blair William Brabin Vega Norfolk
Headquarters
192-194 Johnston Street, Collingwood, VIC, AU
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Blair William Brabin Vega Norfolk
Headquarters
192-194 Johnston Street, Collingwood, VIC, AU
Description

Biome Australia Limited, founded in 2018 and headquartered in Cremorne, Australia, specializes in the development, commercialization, and global distribution of live biotherapeutic and complementary health products.

The company's product line features live biotherapeutics under the Activated Probiotics brand, organic nutritional supplements branded as Activated Nutrients, and athletic performance and recovery items named Activated X Performance. These offerings are accessible to consumers through both community pharmacies and independent health practitioners.

Financial Data

Stock Data

Price chart, volume, and trading data.

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Biome Australia Limited from FRC's valuation model, read against the market price. BIO.AX last traded at AUD 0.29, 21.7× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Biome Australia Limited. Starting points for Biome Australia Limited: P/E 21.7, EPS AUD 0.02, beta 0.97 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Biome Australia Limited. Biome Australia Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Biome Australia Limited. Trailing twelve-month EPS for Biome Australia Limited stands at AUD 0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 0.00AUD 0.02AUD 0.02
Lowest estimateAUD 0.00AUD 0.02AUD 0.02
Highest estimateAUD 0.00AUD 0.02AUD 0.02
Number of analysts011
A year agoAUD 0.00AUD 0.02—
Growth vs a year ago−100.0%+0.6%—

Revenue estimates

TotalThis quarterDec 2026This yearYear to Jun 2027Next yearYear to Jun 2028
Average estimateAUD 11.78MAUD 33.00MAUD 45.30M
Lowest estimateAUD 11.78MAUD 33.00MAUD 45.30M
Highest estimateAUD 11.78MAUD 33.00MAUD 45.30M
Number of analysts111
A year agoAUD 8.86MAUD 23.88M—
Growth vs a year ago+32.9%+38.2%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Biome Australia Limited. Biome Australia Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold BIO.AX20 companies
Compare BIO.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
EXL.AXElixinol Wellness LimitedHealthcareDrug Manufacturers - Specialty & Generic—
EZZ.AXEZZ Life Science Holdings LimitedHealthcareBiotechnology—
HCT.AXHolista Colltech LimitedHealthcareBiotechnology—
NGS.AXNutritional Growth Solutions Ltd.Consumer DefensivePackaged Foods—
S66.AXStar Combo Pharma LimitedConsumer DefensiveHousehold & Personal Products—
SKN.AXSkin Elements LimitedConsumer DefensiveHousehold & Personal Products—
VLS.AXVita Life Sciences LimitedHealthcareDrug Manufacturers - Specialty & Generic—
WNX.AXWellnex Life LimitedConsumer DefensivePackaged Foods—
More Medical - Pharmaceuticals companies
TickerTypeCompanySectorExchangeMkt cap
FSPMFusionPharm, Inc.HealthcareOTC$1,259
GCANThe Greater Cannabis Company, Inc.HealthcareOTC$207,059
GEATFRadiko Holdings Corp.HealthcareOTC$4,453
GEDSFGedeon Richter PLCHealthcareOTC$4.5B
GHTIG-H-3 International Inc.HealthcareOTC—
GRPIGrupo International Inc.HealthcareOTC$1,043
GSACGelStat CorporationHealthcareOTC$247,192
GWLLGoldenwell Biotech, Inc.HealthcareOTC$104.0M
HADVHealth Advance Inc.HealthcareOTC$48,284
HELPCybin Inc. Common StockHealthcareNASDAQ$427.1M
HEWAHealthWarehouse.com, Inc.HealthcareOTC$4.7M
HITIHigh Tide Inc.HealthcareNASDAQ$211.3M
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Biome Australia Limited.

BIO.AX AnalysisGood
Past
1
Growth
5
Health
4
Profit
5
Value
2